CD19 Chimeric Antigen Receptor (CAR) T Cells in Adults With Relapsed/Refractory CD19 Positive Acute Lymphoblastic Leukemia
Clinical trial NCT07361029 · RECRUITING
Trial details
- NCT number
- NCT07361029
- Sponsor
- King Faisal Specialist Hospital & Research Center
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-29
- Primary completion
- 2027-07-01
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.